GEOFFREY F COX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEOFFREY F COX.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEOFFREY F COX. GEOFFREY F COX is a Director in Aviragen Therapeutics, Inc. ($NABI) and a Chairman, President and CEO in rEVO Biologics, Inc. ($GTCB) and a President, CEO and Chairman in rEVO Biologics, Inc. ($GTCB).
Address: C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM 01702 MA
Companies in which GEOFFREY F COX is an Insider
rEVO Biologics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEOFFREY F COX: Chairman, President and CEO, President, CEO and Chairman
Holdings: 87,944 shares
Latest Transaction: Nov 04 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vaxart, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEOFFREY F COX: Director
Holdings: 18,521 shares
Current Value: $21,114
Latest Transaction: May 16 2006
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GEOFFREY F COX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 1.21 | 31,626 | 38,267 | 87,944 | 56.3 K to 87.9 K (+56.16 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Payment of Exercise | F | 2.66 | 2,331 | 6,200 | 56,318 | 58.6 K to 56.3 K (-3.97 %) |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 0.37 | 110,000 | 40,700 | 110,000 | |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 10,800 | 0 | 586,517 | 575.7 K to 586.5 K (+1.88 %) |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 0.31 | 160,000 | 49,600 | 160,000 | |
| Nov 24 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.15 | 1,500 | 225 | 575,717 | 574.2 K to 575.7 K (+0.26 %) |
| Nov 24 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.16 | 40,900 | 6,544 | 574,217 | 533.3 K to 574.2 K (+7.67 %) |